Bansal Wire IPO vs Emcure Pharma IPO

Comparision between Bansal Wire IPO and Emcure Pharma IPO.

IPO Details

Bansal Wire IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Emcure Pharma IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

	Bansal Wire IPO	Emcure Pharma IPO
Logo
Issue Category	Mainline	Mainline
Issue Type	IPO	IPO
Process Type	Book Built Issue	Book Built Issue
Listing At	BSE, NSE	BSE, NSE
Lead Managers	SBI Capital Markets Limited Dam Capital Advisors Ltd (Formerly Idfc Securities Ltd)	Kotak Mahindra Capital Company Limited Axis Capital Limited J.P. Morgan India Private Limited Jefferies India Private Limited
Registrar	Kfin Technologies Limited	Link Intime India Private Ltd
Market Maker
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor	Anchor Investor	Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Bansal Wire IPO is up to ₹745.00 Cr whereas the issue size of the Emcure Pharma IPO is up to ₹1,952.03 Cr. The final issue price of Bansal Wire IPO is ₹256.00 per share and of Emcure Pharma IPO is ₹1,008.00 per share.

	Bansal Wire IPO	Emcure Pharma IPO
Face Value	₹5 per share	₹10 per share
Issue Price (Lower)	₹243.00 per share	₹960.00 per share
Issue Price (Upper)	₹256.00 per share	₹1,008.00 per share
Issue Price (Final)	₹256.00 per share	₹1,008.00 per share
Discount (Retail)
Discount (Employee)		₹90.00 per share
Market Lot Size	58 shares	14 shares
Fresh Issue Size	2,91,01,562 shares	79,36,507 shares
Fresh Issue Size (Amount)	up to ₹745.00 Cr	up to ₹800.00 Cr
OFS Issue Size		1,14,28,839 shares
OFS Issue Size (Amount)		up to ₹1,152.03 Cr
Issue Size Total	2,91,01,562 shares	1,93,65,346 shares
Issue Size Total (Amount)	up to ₹745.00 Cr	up to ₹1,952.03 Cr

IPO Timetable

Bansal Wire IPO opens on Jul 03, 2024, while Emcure Pharma IPO opens on Jul 03, 2024. The closing date of Bansal Wire IPO and Emcure Pharma IPO is Jul 05, 2024, and Jul 05, 2024, respectively.

	Bansal Wire IPO	Emcure Pharma IPO
Anchor Bid Date	Jul 02, 2024	Jul 02, 2024
Issue Open	Jul 03, 2024	Jul 03, 2024
Issue Close	Jul 05, 2024	Jul 05, 2024
Basis Of Allotment (Tentative)	Jul 08, 2024	Jul 08, 2024
Initiation of Refunds (Tentative)	Jul 09, 2024	Jul 09, 2024
Credit of Share (Tentative)	Jul 09, 2024	Jul 09, 2024
Listing date (Tentative)	Jul 10, 2024	Jul 10, 2024
Anchor Lockin End date 1	Aug 07, 2024	Aug 07, 2024
Anchor Lockin End date 2	Oct 06, 2024	Oct 06, 2024

Financials

Bansal Wire IPO P/E ratio is 41.41, as compared to Emcure Pharma IPO P/E ratio of 34.55.

Bansal Wire IPO

Emcure Pharma IPO

Financial

Bansal Wire Industries Limited Financial Information (Restated)

Bansal Wire Industries Limited's revenue increased by 1.99% and profit after tax (PAT) rose by 31.48% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended	31 Mar 2024	31 Mar 2023	31 Mar 2022
Assets	1,264.01	749.05	695.48
Revenue	2,470.89	2,422.57	2,205.07
Profit After Tax	78.80	59.93	57.29
Net Worth	422.37	282.51	223.01
Reserves and Surplus	358.64	273.41	213.91
Total Borrowing	681.14	422.19	413.15
Amount in ₹ Crore

Emcure Pharmaceuticals Limited Financial Information (Restated Consolidated)

Emcure Pharmaceuticals Limited's revenue increased by 11.33% and profit after tax (PAT) dropped by -6.1% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended	31 Mar 2024	31 Mar 2023	31 Mar 2022
Assets	7,806.16	6,672.53	6,063.47
Revenue	6,715.24	6,031.72	5,918.86
Profit After Tax	527.58	561.85	702.56
Net Worth	2,952.28	2,501.13	1,987.55
Reserves and Surplus	2,722.40	2,293.77	1,791.03
Total Borrowing	2,091.94	2,202.42	2,102.19
Amount in ₹ Crore

Promoter Shareholding (Pre-Issue)

73.60%

98.90%

Promoter Shareholding (Post-Issue)

59.92%

78.24%

P/E Ratio

41.41

34.55

Market Cap

₹4007.83 Cr.

₹19029.89 Cr.

ROE

21.19%%

16.90%%

ROCE

18.46%%

19.37%%

Debt/Equity

1.48

0.67

EPS

₹6.18

₹29.17

RoNW

18.27%%

16.87%%

Shares Offered

In the Bansal Wire IPO retail investors (RII) are offered 1,01,85,547 shares while in Emcure Pharma IPO retail investors are offered 1,01,85,547 shares. Qualified institutional buyers (QIB) are offered 58,20,313 shares in Bansal Wire IPO and 38,53,234 shares in Emcure Pharma IPO.

	Bansal Wire IPO	Emcure Pharma IPO
Anchor Investor Reserveration	87,30,468 shares	57,79,850 shares
Market Maker Reserveration
QIB	58,20,313 shares	38,53,234 shares
NII	43,65,234 shares	28,89,926 shares
RII	1,01,85,547 shares	67,43,160 shares
Employee	0 shares	1,08,900 shares
Others
Total	2,03,71,094 shares	1,37,03,538 shares

Bids Received (Subscription)

Bansal Wire IPO subscribed 62.76x in total, whereas Emcure Pharma IPO subscribed 67.87x.

	Bansal Wire IPO	Emcure Pharma IPO
QIB (times)	153.86x	191.24x
NII (times)	54.21x	49.32x
Big NII (times)	55.27x	54.90x
Small NII (times)	52.11x	38.16x
RII (times)	14.37x	7.36x
Employee (times)		8.81x
Other (times)
Total (times)	62.76x	67.87x

Compare with others

Bansal Wire IPO	Emcure Pharma IPO
Unicommerce eSolutions IPO	Brainbees Solutions (Firstcry) IPO
Brainbees Solutions (Firstcry) IPO	Ceigall India IPO
Ceigall India IPO	Akums Drugs and Pharmaceuticals IPO
Akums Drugs and Pharmaceuticals IPO	Sanstar IPO
Sanstar IPO	Bansal Wire IPO
Emcure Pharma IPO	OLA Electric IPO
OLA Electric IPO	Vraj Iron and Steel IPO
Vraj Iron and Steel IPO	Aasaan Loans IPO
Aasaan Loans IPO	Stanley Lifestyles IPO
Stanley Lifestyles IPO	DEE Piping Systems IPO

Comments

Add a public comment...